Trials / Sponsors / Fortis Therapeutics, Inc.
Fortis Therapeutics, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma With Failed Remission | Phase 1 | 2019-04-03 |
| Completed | A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Prostate Cancer Metastatic | Phase 1 | 2019-02-04 |